| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_096a1603c6abd9836906a6226c0cda78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-24 |
| filingDate |
2004-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982f46db3e9d16af0eb0a028570bb90f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd2b228daa32e54624ee807f9192530e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46cd14ef9f29200e28aac921155a5091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0793dd3d8fb7e8088d8c9c03a427df9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff7dff0594ac0462122422e566cfdd9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36dd313e34f22214f6e83f9bf5f7c292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d4c833ca6c62323a5f739260df513f2 |
| publicationDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0401742-A |
| titleOfInvention |
Ritonavir analog compound useful as retroviral protease inhibitor, preparation of ritonavir analog compound and pharmaceutical composition of ritonavir analog compound |
| abstract |
"RITONAVIR ANALOG COMPOUND USEFUL AS A RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF RITONAVIR ANALOG COMPOUND AND PHARMACEUTICAL COMPOSITION OF RITONAVIR ANALOG". The present invention describes the synthesis of a novel ritonavir analog compound which exhibits significantly superior activity to ritonavir in inhibiting HIV protease. Also described are the use of the ritonavir analog compound of the present invention or its salt, ester or prodrug as an active ingredient in pharmaceutical compositions as well as the use of the compound and pharmaceutical compositions in medicine, particularly in the treatment of HIV infection. alone or in combination with other anti-HIV medicines. |
| priorityDate |
2004-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |